NCT02694913View on ClinicalTrials.gov

Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 7, 2019

Study Completion Date

February 7, 2019

Conditions
Lymphoma
Interventions
OTHER

Non Interventional

This is a non therapeutic, pilot study.

Trial Locations (1)

10021

Weill Medical College of Cornell University, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT02694913 - Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies | Biotech Hunter | Biotech Hunter